1.) "There are 4 worldwide pharmaceutical companies that have synthetic CBD extracts - and they do a business in excess of $1 billion annually. MJNA’s products are organically grown - not synthetic."
2.) "As products emerge, the Company (MJNA) plans to contract and partner with other pharmaceutical companies on clinical trials for efficacy of their formulations."
3.) "Many established pharmaceutical companies are researching CBD because of the potential to establish a “blockbuster drug” or drugs from the compound. For the emerging MJNA company, their competitive advantage, secured by international patents and IP rights has an amazing opportunity to expand sales and distribution of these new products."
Market Data 
Markets 
AI
